At our core, we are a team of committed colleagues who believe in and promote diversity, equity, and inclusion. We provide numerous opportunities for interested individuals, regardless of gender, age, religious belief, sexual orientation, race, color, ethnic or social origin, or disability.
In order to support our growing team, we are seeking bright minds with creativity and flexibility. What talents do you possess?
Objectives/Purpose:
- Provide a single point of contact for all Rare Genetics & Hematology (RGH) related activities within the EUCAN Region.
- Support Local Operating Companies (LOCs) in planning and executing Access & Pricing strategies, monitoring progress, and fostering best-practice sharing across LOCs.
- Represent Market Access and EUCAN region in collaboration with the Global Pricing and Access and EUCAN regional cross-functional Integrated Franchise Teams.
- Be an inspiring, knowledgeable, and pragmatic leader, championing Takeda's values, fostering collaboration with cross-functional and global/region/LOC partners to optimize access to Takeda's RGH products for patients across Europe & Canada.
Accountabilities:
- Set clear access priorities for the region and RGH portfolio in alignment with the EUCAN PVA Head, including prioritization of access needs for launch brands, focus markets, and growth initiatives.
- Continuously monitor PR&A developments in the region and alert region, country, franchise, brand, and PVA teams to healthcare system developments, competitor activities, or other events within the region that could impact pricing/market access for Takeda's portfolio.
- Lead the collection and dissemination of information, data, insight, and best practices on regional and country market access requirements to ensure local requirements are met.
- Lead access-related launch preparedness and key growth initiatives to facilitate optimal pricing and reimbursement for each country within the region, according to global strategy.
- Provide required regional market access support to the countries based on their local needs and available resources.
- Represent EUCAN Market Access within the EUCAN Integrated Franchise Teams and Global Product Teams.
- Lead the regional pricing approval process and management for the relevant EUCAN portfolio.
- Identify needs for development of market access capabilities within the region and coordinate training with other relevant functions.
- Provide a single point of contact for all access-related topics within the region to relevant internal stakeholders.
- Champion the regional and country needs within Takeda and ensure required resources are provided to the region for PVA activities.
Core Elements Related to this Role:
- Deep understanding of regional and country market access requirements, the evolving environment, and future trends to ensure market access needs are met.
Dimensions and Aspects:
- Technical/Functional (Line) Expertise: Strong understanding of HTA/payer environment, pharmacoeconomics, HEOR, and epidemiology. Experience in pricing, including alternative pricing schemes (e.g., risk-sharing and managed entry agreements) and strategy implementation at the local/regional level desired. Strong understanding of HE/OR principles and familiarity with HEOR/P&R dossiers (e.g., Global Value Dossiers).
- Leadership: Creates an environment that inspires and enables people to move the organization forward. Builds strong win/win partnerships across functions and countries. Demonstrates strategic enterprise thinking and recognizes relationships within the organization. Engages with diverse stakeholders and manages their expectations. Delivers superior results and elevates capabilities of the organization. Establishes networks and processes to gain permanent actionable insights on the business. Questions the status quo and champions Takeda values.
- Decision-making and Autonomy: Works on abstract problems across access-related areas of the business. Provides direction/decision making on access-related topics across the region. Refers access issues with impact beyond the region to the Head of EUCAN PVA, Global Pricing and Access team, and/or relevant functional lead.
- Interaction: Encourages solutions-oriented thinking, fosters a leadership culture, and promotes Takeda-ism characteristics. Effectively navigates the changing external and internal business environment. Negotiates and collaborates with internal and external business partners and resolves conflicts constructively. Builds strong partnerships and respects role clarity with other interfacing Takeda functions.
- Innovation: Visionary and forward-thinking with the ability to influence and drive organizational change and continuous innovation. Comfortable challenging the status quo and bringing forward new solutions. Ability to take risks in creating and testing untried solutions to business issues.
Education, Behavioral Competencies, and Skills:
- University degree required, advanced degree in related field (e.g., MA, MBA, MPH, MPA preferred).
- 5+ years of pharmaceutical commercial experience, including local and/or regional market access experience.
- Strong understanding of the global payer environment, including coverage and reimbursement, pricing and contracting, formulary management, health technology assessment, HTA, and payment policy.
- Demonstrated ability to successfully lead cross-functional teams, foster collaboration, and succeed in a highly matrixed environment.
- Ability to conduct landscape analysis of the external pricing and reimbursement environment and synthesize relevant information to develop strategic plans.
- Ability to develop and test global and region-specific value messages.
- Ability to develop tools to support regions in product value demonstration and communication.
- Excellent communication skills, both oral and written.
- Direct payer experience and/or experience in product commercialization desirable.
- Prior regional or global experience strongly preferred.
- Strategic planning and health policy experience strongly preferred.
- Strong understanding of strategic pricing and contracting, including innovative approaches such as risk-sharing deals.
- Ability to review clinical and health economic literature, including clinical trial design and results, and pharmacoeconomic studies to understand implications for payers.